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Phospholipase C2 Modulates Integrin Signaling in the Osteoclast by
Affecting the Localization and Activation of Src Kinase†
Holly Epple,1,2‡ Viviana Cremasco,3‡ Kaihua Zhang,3 Dailing Mao,3
Gregory D. Longmore,1,2* and Roberta Faccio2,3*
Departments of Medicine,1 Cell Biology,2 and Orthopedics,3 Washington University, St. Louis, Missouri
Received 14 February 2008/Accepted 21 March 2008
Integrin engagement induces a cascade of signaling pathways that include tyrosine phosphorylation of
numerous proteins that lead to modulation of the actin cytoskeleton. Src is a major intracellular mediator of
integrin-dependent functions, but the mechanism(s) by which Src is regulated in response to integrin signals
is not fully understood. Here, we demonstrate an important role for phospholipase C gamma 2 (PLC2) in Src
activation in the osteoclast. Through analysis of primary cells from PLC2/ mice, PLC2 was found to be
an important regulator of v3 integrin-mediated bone osteoclast cell adhesion, migration, and bone resorp-
tion. Adhesion-induced PYK2 and Src phosphorylation is decreased in the absence of PLC2, and the
interaction of Src with 3 integrin and PYK2 is dramatically reduced. Importantly, PLC2 was found to be
required for proper localization of Src to the sealing actin ring, and this function required both its catalytic
activity and adapter domains. Based on these results, we propose that PLC2 influences Src activation by
mediating the localization of Src to the integrin complex and thereby regulating integrin-mediated functions
in the osteoclast.
Integrins are transmembrane proteins that serve as a link
between the extracellular matrix and the cellular cytoskele-
ton and are a primary means by which the cell interacts with
and responds to its environment (16, 19). Integrin engage-
ment induces various intracellular signaling responses lead-
ing to reorganization of the actin cytoskeleton, including
activation of protein tyrosine kinases (5, 12, 15, 16). By
modulating these signaling pathways, integrins can affect
cellular processes such as adhesion, migration, proliferation,
and apoptosis (18, 33).
Integrins are intimately linked to the function of some spe-
cialized cell types, such as bone-derived osteoclasts. Osteo-
clasts are giant, multinucleated cells that form from hemato-
poietic bone marrow precursor cells in response to the
osteoclastogenic factors receptor activator of NFB ligand
(RANKL) and macrophage colony stimulating factor (M-
CSF). Osteoclasts remove mineralized bone matrix during
bone modeling and remodeling (4, 36). In order to resorb
bone, the osteoclast must adhere tightly to the bone surface
and does so by reorganizing the actin cytoskeleton to establish
a sealing zone. Next, acids and lysosomal enzymes must be
secreted into the resorption lacunae to break down the min-
eralized bone matrix. Finally, osteoclasts migrate over the bone
surface so as to sustain resorptive activity (2, 31).
The bone-resorptive function of osteoclasts is dependent on
integrin receptor engagement with the bone extracellular ma-
trix (26, 27, 32). Osteoclasts specifically express high levels of
the v3 integrin (7, 26). Mice lacking 3 integrin exhibit late-
onset osteopetrosis, and osteoclasts from these mice are de-
fective in adhesion, spreading, actin ring formation, and bone
resorption in vitro (9, 22). Since integrins are crucial to the
unique biologic function of osteoclasts and primary osteoclasts
can be readily isolated and cultured ex vivo, osteoclasts provide
a particularly good cellular system in which to elucidate inte-
grin-mediated signaling mechanisms and correlate these
mechanisms with relevant biologic function.
Activation of integrin receptor complexes leads to remodel-
ing of the actin cytoskeleton through the formation and acti-
vation of a large signaling complex called the “adhesion com-
plex” (7). The adhesion complex contains enzymes and
adaptor and scaffolding proteins. Src and PYK2, two enzymes
implicated in signaling from the 3 integrin, have been shown
to promote bone resorption (3, 8). Following v3 integrin
engagement, c-Src is phosphorylated at Tyr416, activating its
kinase activity and inducing an interaction between the Src
homology 2 (SH2) domain of Src and PYK2 (1, 8). Calcium
signals lead to PYK2 autophosphorylation and subsequent fur-
ther tyrosine phosphorylation by Src (8, 17).
Recent findings have demonstrated the importance of im-
mune receptor-activated motif (ITAM)-containing receptors
Dap12 and FcR in modulation of integrin signaling events
(23). Deletion of Dap12 in osteoclasts leads to dysfunctional
cells with aberrant actin organization and impaired bone-re-
sorptive capacity (9). Indeed, c-Src, the v3 integrin, and the
ITAM motif of Dap12 appear to act in concert to modulate
osteoclastic bone resorption (40). However, in these cells ac-
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tivation of Src occurred independently of the ITAM receptor
(40). Thus, the means by which c-Src is recruited to the v3
receptor, fully activated, and modulates integrin signaling, par-
ticularly in osteoclasts, remains to be elucidated.
Phospholipase C gamma (PLC) is activated downstream of
ITAM-containing receptors in several hematopoietic cells.
Two isoforms exist, PLC1 and PLC2; the former is more
widely expressed, while the latter is confined to cells of the
hematopoietic compartment. Like other PLC proteins, PLC
regulates intracellular calcium levels and protein kinase C ac-
tivation via cleavage of the membrane phospholipid phospha-
tidylinositol-4,5-bisphosphate (PIP2) (6). PLC is unique
among the PLC family members, however, in that in addition
to its enzymatic activity, PLC can also act as an adaptor
protein via two SH2 domains and an SH3 domain (6).
Recent data have implicated PLC in integrin-mediated
functions. Phosphorylation of PLC1 at integrin complexes in
fibroblasts contributes to motility regulation (14), while in
platelets, PLC2 phosphorylation, downstream of the IIb3
integrin, is essential for cell spreading (38). Engagement of the
v3 integrin in osteoclasts also induces phosphorylation of
PLC2 in a Src-dependent manner (25), but the significance of
integrin-mediated PLC2 signaling to osteoclast function is
not known.
PLC2/ mice are osteopetrotic and have decreased num-
bers of osteoclasts in vivo and in vitro due to defective NFAT2
upregulation (20). NFAT2 is a critical transcription factor ac-
tivated by RANKL and controls osteoclast differentiation (21).
Interestingly, NFAT2 overexpression promotes osteoclasto-
genesis even in the absence of RANKL signals (21). Here, we
show that exogenous expression of NFAT2 in PLC2/ cells
is able to restore the abilities of PLC2/ cells to differentiate
into mature osteoclasts, but these cells cannot resorb bone.
Utilizing primary cells from PLC2/ mice, we show that
PLC2 is required for the integrin-dependent functions of
osteoclast adhesion, migration, and bone resorption. Following
integrin engagement, PLC2 was found to affect Src activation
by modulating the efficient recruitment of Src to the osteoclast
actin ring at the plasma membrane and thus influencing the
adhesion-induced associations between Src, 3 integrin, and
PYK2. We conclude that PLC2 is an important mediator of
integrin signaling in the osteoclast.
MATERIALS AND METHODS
Primary cell culture. Wild-type (WT) and PLC2/ mice on a C57BL/6
background have been previously described (37). Bone marrow-derived macro-
phages (BMDM) were isolated from 6- to 8-week-old mice as previously de-
scribed (9, 24). Briefly, the marrow spaces of mouse long bones were flushed with
serum-free alpha medium (Gibco). Isolated cells were plated at a concentration
of 5  106 cells per p100 petri dish and grown in the presence of 100 ng/ml
M-CSF for 2 to 5 days. To form osteoclasts, macrophages were cultured on tissue
culture-treated dishes with 100 ng/ml glutathione S-transferase–RANKL and 10
ng/ml M-CSF for 5 days, with fresh medium added every 48 h.
Plasmids, retrovirus generation, and antibodies. Full-length PLC2 was ob-
tained from M. Katan (Cancer Research UK Centre for Cell and Molecular
Biology, Chester Beatty Laboratories) and cloned into the blasticidin-resistant
pMX retroviral vector. PLC2 mutants were made using a QuikChange XL
site-directed mutagenesis kit (catalog no. 200517; Stratagene), following the
manufacturer’s instructions. NFAT2 was obtained from A. Rao (Harvard Med-
ical School, Boston, MA) and cloned into the puromycin-resistant pMX retro-
viral vector. To generate retrovirus, PLAT-E cells, which stably express retroviral
packaging genes (24), were transfected with expression vector by using Transit
transfection reagent and the manufacturer’s protocols (Mirus, Madison, WI).
Viral supernatants were collected on day 2 and day 3 posttransfection and
immediately used to infect freshly isolated BMDM. After 24 h, medium contain-
ing the appropriate selection (2 g/ml puromycin or 1 g/ml blasticidin) was
added to cells for 48 h to select for expressing cells. For Western blotting and
immunofluorescence analysis, the following antibodies were used: anti-PLC2,
PLC1, NFAT2, polyclonal Src, actin (Santa Cruz), 3 integrin, PYK2 (BD),
p402 PYK2 (Biosource), p416 Src (Cell Signaling), and monoclonal Src (gener-
ous gift from Steve Teitelbaum).
Cell adhesion, migration, and bone resorption. BMDM were treated with
differentiation medium for 2 days to produce prefusion osteoclasts (preOCs).
Cells were starved for 6 h, lifted from the dish by using 0.5 mM EDTA in
phosphate-buffered saline (PBS) and a cell lifter (Corning Inc.), and plated on
glass coverslips coated with 5 g/ml vitronectin (BD Biosciences). After various
times, cells were fixed in 4% paraformaldehyde for 10 min. The number of
adherent cells per field was enumerated using a light microscope (Olympus).
The bottoms of 8-m-pore Boyden chamber membranes (Corning Inc.) were
coated with 5 g/ml vitronectin and blocked in 2% heat-inactivated bovine serum
albumin for 30 min. Serum-free medium with or without 100 ng/ml M-CSF was
added to the bottom chamber, and 100,000 day 2 preOCs were added to the
upper Boyden chamber membrane in serum-free medium. Cells were allowed to
migrate for 6 to 8 h at 37°C. Cells remaining on the upper membrane were
removed by mechanical force while cells on the bottom membrane were fixed in
100% methanol for 15 min. Cells were stained with modified Giemsa stain
(Sigma), and the number of cells per field was enumerated using an inverted light
microscope (Olympus).
Bone resorption analysis was completed as described previously (39). Briefly,
macrophage cells were plated on dentin slices and cultured with 10 ng/ml M-CSF
and 100 ng/ml RANKL for 10 days, with fresh medium added every 2 days. Cells
were removed from the bone surface by using mechanical force and 2 N NaOH.
Bone slices were stained with 20 g/ml peroxidase-conjugated wheat germ ag-
glutinin for 30 min (Sigma). For development, 3,3	-diaminobenzidine (0.52
mg/ml in PBS containing 0.1% H2O2) was added onto the bone slices for 15 min.
Bone resorption pits were analyzed using a light microscope (Olympus) and
quantified using Image J software.
Immunoprecipitation and kinase assays. For immunoprecipitation, cells were
harvested in lysis buffer (10 mM Tris, pH 7.4, 150 mM NaCl, 1% NP-40, 1 mM
EDTA, 10% glycerol) supplemented with protease inhibitors and clarified by
centrifugation. The protein concentration of each sample was determined using
bicinchoninic acid protein assay (Pierce) and normalized. Samples were incu-
bated with primary antibody overnight at 4°C and with protein G agarose beads
(Amersham) for 1 h. Beads were washed three times in lysis buffer and immu-
noprecipitates subjected to Western blotting.
For Src kinase assays, preOC cells were starved for 6 h and then stimulated for
45 min on a vitronectin-coated surface. Whole-cell lysates were collected in lysis
buffer (see above), normalized, and immunoprecipitated with 2 g monoclonal
Src antibody for 1 h at 4°C. Beads were washed two times in lysis buffer and one
time in reaction buffer (Upstate). The Src kinase assay was completed following
the manufacturer’s instructions (Upstate Biotechnology).
Lipase assay. Infected cells were harvested in lysis buffer, and WT PLC2 or
PLC2 mutants were immunoprecipitated using a mouse anti-FLAG M2-aga-
rose beads (Sigma). After 2 h, beads were washed and resuspended in lipase
buffer (50 mM NaH2PO4, 100 mM KCl, 0.8 mM EGTA, 0.8 mM CaCl2) plus
0.15% OG (N-octyl--D-glucopyranoside). Tritium-labeled PIP2 was added to
the sample for 15 min, and then inorganic phase was recovered using a mixture
of HCl, KCl, and chloroform. Scintillation fluid was added to the inorganic
phase, and radioactive counts were determined.
Immunofluorescence and microscopy. Cells were fixed with 4% paraformal-
dehyde for 10 min and permeabilized in blocking buffer (0.015% Triton X-100
[Sigma], 3% normal goat serum, and 1% immunoglobulin G-free bovine serum
albumin [Jackson Immunological Research] in PBS) for 30 min. Primary anti-
body was added for 12 h at 4°C and then rinsed three times with PBS. Secondary
antibody was added for 1 to 2 h at room temperature and then washed three
times with PBS. Coverslips were incubated with fluorescein isothiocyanate- or
CY3-phalloidin (Molecular Probes) and DAPI (4	,6	-diamidino-2-phenylindole)
(to identify nuclei) for 10 min at room temperature, washed, and mounted on
glass slides. Slides were analyzed using an Olympus IX70 inverted microscope
with either a 10 APO, 0.4-numerical-aperture lens or a 60 APO, 1.4-numer-
ical-aperture lens. Images were captured with a CoolSnap camera (Roper Sci-
entific) and analyzed using Metamorph software (Universal Imaging Corpora-
tion). All images from the same set of experiments were taken without changing
the camera settings.
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RESULTS
Overexpression of NFAT2 rescues osteoclast differentiation
defect of PLC2/ BMDM but not bone resorption. Loss of
PLC2 in mice results in osteopetrotic bones (20). While os-
teoclasts are present in the bones of PLC2/ mice, their
numbers are significantly reduced, and primary BMDM from
PLC2/ mice fail to became mature, multinucleated osteo-
clasts when treated with RANKL and M-CSF in ex vivo cul-
tures (20). This defect in differentiation is due to a decreased
upregulation of NFAT2 (20). Since overexpression of NFAT2
in BMDM has been shown to increase the RANKL-induced
differentiation capacities of these cells (21), we reasoned that
overexpression of NFAT2 in the PLC2/ BMDM could
rescue the defect in osteoclast differentiation. BMDM were
isolated from the long bones of WT and PLC2/ mice and
retrovirally transduced with empty vector, NFAT2, or PLC2.
After selection, cells were treated with M-CSF and RANKL
for 5 to 7 days to induce osteoclast differentiation. Cells were
then fixed and stained to identify tartrate-resistant acid phos-
phatase-positive (TRAP), multinucleated osteoclasts. WT
cells expressing both empty vector and NFAT2 formed large,
TRAP osteoclasts (Fig. 1A and B). Expression of NFAT2 in
WT cells increased the number of osteoclasts formed com-
pared to expression of empty vector alone (Fig. 1F), as previ-
ously observed (21). PLC2/ cells expressing empty vector
did not form osteoclasts (Fig. 1C); however, expression of
either NFAT2 or PLC2 in PLC2/ cells was able to rescue
the defect in osteoclast differentiation (Fig. 1D and E). Nota-
bly, expression of NFAT2 in PLC2/ cells did not promote
differentiation to the same extent as that seen with WT cells
overexpressing NFAT2 (Fig. 1F). Importantly, we did not de-
tect any difference in RANK (the receptor for RANKL) ex-
pression levels in the two cells types either with or without
NFAT2 expression (Fig. 1G). These results confirmed that
upregulation of NFAT2 is an essential function of PLC2 in
promoting osteoclast differentiation and that osteoclast differ-
entiation of PLC2/ cells could be rescued by simply over-
expressing NFAT2.
Since the ability to remodel and resorb the bone is a unique
feature of the osteoclast, we asked whether overexpression of
NFAT2 could rescue the capacities of PLC2/ osteoclasts to
resorb bone. WT and PLC2/ BMDM transduced with ei-
ther NFAT2 or PLC2 were plated on a dentine bone surface
in the presence of M-CSF and RANKL. WT osteoclasts ex-
pressing either empty vector or NFAT2 displayed numerous
actin rings (Fig. 1H and inserts). Although PLC2/ cells
expressing NFAT2 formed mature osteoclasts, the actin rings
appeared abnormal. Compared to WT or PLC2/ cells res-
cued with full-length PLC2, they were small and contained
central dots of actin condensed in the middle (Fig. 1H, phal-
loidin-stained images). Mirroring the abnormal actin ring,
PLC2/ osteoclasts expressing NFAT2 exhibited decreased
bone-resorptive capacity compared to PLC2-expressing cells
(Fig. 1H [quantified in Fig. 1I]). In sum, although expression of
NFAT2 rescued the PLC2/ defect in osteoclast differenti-
ation, PLC2 was critical for proper osteoclast actin ring for-
mation and bone resorption.
PLC2 is expressed in mature osteoclasts and localizes to
the actin ring. To determine the role of PLC2 in osteoclast
function, we first examined the expression of PLC isoforms in
response to RANKL-induced osteoclast differentiation. BMDM
from WT and PLC2/ mice were treated with M-CSF and
RANKL to induce osteoclast differentiation. Total cell lysates
were collected every day for 5 days and Western blotted to
determine the levels of PLC2 and PLC1 protein. RANKL-
induced osteoclast differentiation did not alter the levels of
either isoform (Fig. 2A). Importantly, PLC1 levels were not
altered in PLC2/ cells compared to those in WT cells,
suggesting that PLC1 did not compensate for the loss of
PLC2 (Fig. 2A).
Next, we set out to identify the subcellular localization of
PLC2 in primary osteoclasts. WT and PLC2/ BMDM
were retrovirally transduced with empty vector or NFAT2 and
grown in the presence of RANKL to form mature osteoclasts.
PLC2 was found to localize to the edge of the WT osteoclast,
colocalizing with the actin ring (Fig. 2B, merge in yellow).
PLC2 localization was not altered by overexpression of
NFAT2, since the immunostaining pattern was the same in WT
cells expressing either empty vector or NFAT2 (Fig. 2B, top
and middle rows). As an antibody specificity control, PLC2/
osteoclasts expressing NFAT2 were probed with the PLC2
antibody (Fig. 2B, bottom row). That PLC2 localized to the
actin rings of mature osteoclasts, combined with the observa-
tions that PLC2-null cells formed abnormal actin rings and
failed to resorb bone, strongly suggested that PLC2 governed
critical integrin-dependent signaling events important for
osteoclast function.
PLC2 promotes preOC adhesion, spreading, and hapto-
tactic migration. v3 integrin function is critical for osteoclast
adhesion, migration, and ultimately bone resorption (9, 22).
Since PLC2 has been biochemically implicated as a potential
component of the integrin adhesive complex (25), we asked
whether PLC2 contributed to v3 integrin function in the
osteoclast. Although PLC2/ BMDM fail to undergo termi-
nal osteoclast differentiation, they could form mononuclear
preOCs when exposed to RANKL for 2 days, as demonstrated
by the fact that the levels of expression of 3 integrin and Src,
early markers of osteoclast commitment, were similar to those
in WT cells (Fig. 3A). Thus, we tested the adhesion capacities
of WT and PLC2/ preOCs plated on vitronectin-coated
plates for the indicated times. There were decreased numbers
of adherent PLC2/ preOCs at all time points examined
compared to WT control levels (Fig. 3B), and importantly, all
null cells had round morphologies, suggesting a spreading de-
fect (Fig. 3C). Expression of PLC2 in PLC2/ cells rescued
the defects in adhesion and spreading (Fig. 3B and C). NFAT2
overexpression in PLC2/ preOCs did not rescue the adhe-
sive defect of these cells, indicating that NFAT2 expression,
per se, did not affect integrin-mediated adhesion (data not
shown).
Next, the abilities of WT and PLC2/ preOCs to migrate
were determined using a Boyden chamber assay. Haptotactic-
stimulated migration toward the vitronectin matrix (M-CSF)
and M-CSF-induced chemotactic migration (M-CSF) were
determined by counting the number of cells that migrated to
the bottom of the Boyden chamber membrane. PLC2/
preOCs exhibited decreased haptotaxis toward vitronectin rel-
ative to WT preOCs (Fig. 3D). In both WT and PLC2/
preOCs, the addition of M-CSF induced twofold increases in
3612 EPPLE ET AL. MOL. CELL. BIOL.
 o
n
 January 11, 2014 by guest
http://m
cb.asm
.org/
D
ow
nloaded from
 
FIG. 1. Overexpression of NFAT2 rescues the defect in RANKL-dependent osteoclast differentiation of PLC2/ cells but not bone
resorption. (A to E) WT and PLC2/ BMDM were retrovirally infected with pMX (empty vector) (A, C), pMX-NFAT2 (B, D), or pMX-PLC2
(E). Cells were grown in the presence of 10 ng/ml M-CSF and 100 ng/ml RANKL for 5 to 7 days, fixed, and TRAP stained. TRAP osteoclasts
were observed using a light microscope with a 10 objective. (F) The number of TRAP osteoclasts per well was determined and graphed for each
sample. (G) WT and PLC2/ BMDM were retrovirally infected with empty vector (pMX) or NFAT2 and grown in the presence of 10 ng/ml
M-CSF and 100 ng/ml RANKL. After 3 days, cells were lysed and Western blotted (WB) for the indicated protein. (H) WT and PLC2/ BMDM
retrovirally infected with empty vector (pMX), NFAT2 (pMX-NFAT2), or PLC2 (pMX-PLC2) were cultured on dentin for 10 days with
RANKL and M-CSF, fixed, and stained with fluorescein isothiocyanate-phalloidin to detect actin rings (top row; 10 objective). Inserts were
enlarged fourfold. Cells were removed with 2 N NaOH and resorption pits visualized by staining with peroxidase-conjugated wheat germ agglutinin.
Pits were analyzed by light microscopy with a 10 objective. Black lines delineate the resorbed areas (bottom row). (I) Area of bone resorption
per field was determined using Image J software and graphed for each sample.
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migration compared to the level for vitronectin alone (Fig.
3D). This indicated that the response of PLC2/ preOCs to
M-CSF-stimulated chemotaxis was not altered; rather, the mi-
gration defect resulted primarily from an impaired haptotactic
response to vitronectin, an integrin-dependent function. These
data indicated that PLC2 played an important role in osteo-
clast adhesion, spreading, and migration, all integrin-depen-
dent processes important for the bone-resorptive function of
the osteoclast.
PLC2 promotes activation of Src and PYK2 in response to
integrin engagement. How, then, does PLC2 influence inte-
grin function in the osteoclast? To determine whether the
absence of PLC2 influenced integrin complex-associated ki-
nase activity, we compared the integrin-induced tyrosine phos-
phorylation (i.e., activation) levels of Src and PYK2 in WT and
PLC2/ preOCs following adhesion to vitronectin. PLC2/
cells showed decreased phosphorylation of tyrosine 416 of Src
and tyrosine 402 of PYK2, which was normalized following
retroviral reintroduction of PLC2 into PLC2/ cells (Fig.
4A). Since PLC2/ cells expressed normal levels of PLC1
(Fig. 2A), it was unlikely that PLC1 was compensating for the
absence of PLC2. To confirm the nonredundant role of these
two isoforms, their activation following adhesion was deter-
mined. Only PLC2, and not PLC1, became phosphorylated
following attachment to vitronectin (see Fig. S1 in the supple-
mental material).
FIG. 2. PLC2 expression is stable during osteoclast differentiation, and PLC2 is localized to the actin ring in the osteoclast. (A) WT and
PLC2/ BMDM were grown in the presence of 10 ng/ml M-CSF and 100 ng/ml RANKL for 5 days. Whole-cell lysates were collected every 24 h
and Western blotted (WB) for the indicated proteins. (B) WT and PLC2/ BMDM were retrovirally infected with pMX (empty vector) (top
row) or pMX-NFAT2 (bottom two rows). Osteoclasts were probed with PLC2 polyclonal antibody and costained with Cy3-phalloidin and DAPI.
Images were obtained with an Olympus IX70 inverted fluorescence microscope using a 60 APO, 1.4-numerical-aperture lens. Scale bar, 5 m.
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The phosphorylation of Src at tyrosine 416 correlates with its
kinase activity (28). We also directly measured the kinase ac-
tivities of Src in WT and PLC2/ preOCs following integrin
activation in an in vitro kinase assay. Src activity from
PLC2/ cells stimulated by adhesion to vitronectin was de-
creased 50% compared to that from WT cells (Fig. 4B). To-
gether, these data indicated that PLC2 was critical for the
activation of Src and PYK2 kinases following integrin activa-
tion.
PLC2 promotes the formation of a 3 integrin/Src/PYK2
complex. In addition to regulating enzyme activity, phosphor-
ylation of components of the adhesion complex can influence
protein-protein interactions within the complex (8). Therefore,
we asked whether the absence of PLC2 influenced the for-
mation of the integrin adhesive complex in response to integrin
engagement. WT and PLC2/ preOC cells were plated on a
vitronectin-coated surface, and at various times postadhesion,
Src or PYK2 was immunoprecipitated from cell lysates and
bound products Western blotted for components of the inte-
grin adhesive complex. In WT cells, an adhesion-induced in-
teraction of Src with 3 integrin and PYK2 was detected;
however, these same associations were not detected in the
PLC2/ cells (Fig. 5A). Furthermore, PYK2 and PLC2
also associated following integrin-dependent engagement, as
detected specifically in WT cells (Fig. 5B). When PYK2 was
immunoprecipitated, an adhesion-induced interaction with Src
was detected in WT lysates; however, this interaction was
barely detectable in PLC2/ lysates (Fig. 5B). To determine
whether PLC catalytic activity was required for the formation
of the Src/PYK2/3 complex, WT adherent cells were treated
with the PLC inhibitor U73122 for 3 h. As expected, un-
treated WT cells fully supported the association of Src with
PYK2 and 3; however, this complex was not detected in cells
treated with the PLC inhibitor (Fig. 5D). These data indi-
FIG. 3. PLC2/ preOCs exhibit defective adhesion and spreading on vitronectin and a decreased haptotactic migration response. (A) WT
and PLC2/ BMDM were allowed to differentiate for 2 to 3 days in osteoclastogenic medium to form preOCs. Cell lysates were Western blotted
(WB) for the indicated proteins. (B, C) WT (filled squares), PLC2/ (filled circles), and PLC2/ plus pMX-PLC2 (open triangles) preOCs
were serum and cytokine starved for 6 h, plated on vitronectin (5 g/ml), washed, and fixed after various times. Cells were imaged with a light
microscope to observe spreading (C) and number of adherent cells per field enumerated (B). Each data point represents an average of eight
independent fields, and standard deviations were calculated. An asterisk represents a P value of 
0.001. Scale bar, 10 m. (D) WT and PLC2/
preOCs were allowed to migrate toward a filter coated with vitronectin in the absence () or presence () of 100 ng/ml M-CSF. Migrated cells
were stained with Geimsa and counted under a light microscope. At least three fields were analyzed per data point. The increase observed in WT
cells after addition of M-CSF was considered significant, with a P value of 
0.001.
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cated that PLC2 contributed to the association of Src and
PYK2 with the integrin adhesion complex following integrin
activation.
PLC2 controls the subcellular localization of Src. One
possible mechanism by which PLC2 could influence Src and
PYK2 activation at the adhesive complex is by facilitating lo-
calization of these proteins to the integrin adhesive complex, as
suggested by the coimmunoprecipitation experiments pre-
sented above. To determine whether PLC2 affected the lo-
calization of Src and PYK2 to integrins in the osteoclast, WT
or PLC2/ BMDM were transduced with empty vector,
NFAT2, or full-length PLC2 and differentiated to form ma-
ture osteoclasts. Phalloidin staining, to visualize the actin cy-
toskeleton, revealed that equivalent actin rings formed in both
WT and PLC2/ mature osteoclasts expressing either
NFAT2 or PLC2 when plated on glass (Fig. 6A to C), in
contrast to what was observed when PLC2/ cells were
plated on a bone surface (Fig. 1G). The staining patterns for
total PYK2 were similar in WT and PLC2/ cells, localizing
at the actin ring (Fig. 6D to F). However, PYK2 phosphory-
lated at Y402 was found at the peripheral membrane juxta-
posed to the actin ring only in cells expressing PLC2 (Fig. 6G
to I; also see Fig. S2 in the supplemental material). Both total
and activated forms of Src were also mislocalized in PLC2/
cells (Fig. 6J to O). In WT cells, Src localized exclusively to the
outer edge of the cell in close proximity to the phalloidin-
stained actin ring, while in PLC2/ cells, Src staining was
present diffusely throughout the cell and did not specifically
localize to the actin ring (Fig. 6J to L). Staining with a phos-
phospecific antibody to tyrosine 416 of Src (active Src) re-
vealed the presence of p416-Src in WT cells predominantly at
the edge of the cell juxtaposed to the actin ring, while p416-Src
staining was dramatically reduced in PLC2/ osteoclasts
(Fig. 6M and O; also see Fig. S2 in the supplemental material).
Importantly, reintroduction of full-length PLC2 in PLC2/
cells resulted in Src and p416-Src staining patterns similar to
those in WT osteoclasts (Fig. 6L and O). The faint staining of
activated Src and PYK2 observed in PLC2/ osteoclasts
correlated with decreased phosphorylated levels of the two
proteins following attachment to vitronectin, as determined by
Western blotting (Fig. 4A), indicating that PLC2 controlled
both activation and localization of p-Src and p-PYK2 in osteo-
clastic cells.
PLC2 catalytic activity and adapter function are required
for Src localization. PLC2 contains a catalytic domain that
converts PIP2 into IP3 (inositol-1,4,5-trisphosphate) and DAG
(1,2-sn-diacylglycerol) and two tandem SH2 motifs and one
SH3 domain involved in protein-protein interaction. To deter-
mine the mechanism by which PLC2 modulated Src localiza-
tion and activation, we infected PLC2-null BMDM with a
catalytic inactive PLC2 construct (PLC2 H/F carrying the
mutations H327F/H372F) and with mutants carrying point mu-
tations in either the two tandem SH2 motifs (PLC2 SH2 with
point mutations R564K/R672K) or the SH3 domain (PLC2
SH3 carrying the mutation P820L). We first analyzed the ca-
pacities of these mutated forms of PLC2 to support osteoclast
differentiation and bone resorption. As previously shown (20),
PLC2 catalytic activity was required for proper formation of
multinucleated spread osteoclasts (Fig. 7A). In addition, mu-
tations in the SH2 motifs, but not in the SH3 domain, also
FIG. 4. PLC2/ cells exhibit a defect in Src and PYK2 phosphorylation and decreased Src kinase activity. (A) WT and PLC2/ preOCs
infected with empty vector (pMX) or PLC2/ cells infected with pMX-PLC2 were starved for 6 h and stimulated by adhesion to vitronectin
for the indicated times. Whole-cell lysates were Western blotted for the indicated proteins. (B) WT and PLC2/ preOCs were starved and
stimulated by adhesion to vitronectin for 45 min. Whole-cell lysates were collected and normalized. From equal amounts of protein, endogenous
Src was immunoprecipitated and kinase activity determined in vitro, using an exogenous substrate. Counts per minute (CPM) of 32P-labeled
substrate were determined using a scintillation counter.
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blocked osteoclast differentiation compared to cells expressing
WT PLC2 (Fig. 7A and data not shown). Control experiments
demonstrated that these mutants were expressed at similar
levels following retroviral transduction (Fig. 7B). Furthermore,
we also confirmed that PLC2 H/F exhibited 70% decreased
lipase activity in vitro compared to cells expressing WT PLC2,
while the catalytic activity in cells expressing the PLC2 SH2
mutant was intact (Fig. 7C). Next, we tested the abilities of
these two PLC2 mutants to confer bone resorption capacity
and to promote Src localization in PLC2/ cells. NFAT2
was cotransfected with PLC2 H/F or SH2 mutants so as to
ensure proper osteoclast differentiation. Mutation of the cat-
alytic domain or disruption of the adapter function affected the
capacities of the osteoclasts to resorb bone (Fig. 7D and E),
while not altering the localization of PLC2 at the cell periph-
ery (Fig. 7F). Importantly, Src localization remained altered in
cells expressing PLC2 H/F and PLC2-SH2 mutants com-
pared to that in WT osteoclasts or osteoclasts transduced with
WT PLC2 (Fig. 8). In fact, while Src was primarily found at
the cell periphery, localizing at the actin ring, in cells express-
ing full-length PLC2 (Fig. 8A to C and G to I), the kinase
clustered in different areas of the cell, sometimes assuming a
perinuclear distribution, in osteoclasts expressing PLC2 H/F
or PLC2-SH2 mutants.
These data indicated that the catalytic activity and the
adapter function of PLC2, conferred by the two SH2 motifs,
were both independently required for proper localization of
Src to the membranes of osteoclasts as well as efficient bone
resorption. Overall, these findings suggested that appropriate
localization of Src could be a critical mechanism by which
PLC2 affects integrin function in osteoclasts.
DISCUSSION
Considering the role of integrins in essential cellular pro-
cesses, it is important to elucidate the precise molecular events
that occur in response to integrin engagement. The lipase
PLC is phosphorylated and enzymatically activated upon in-
tegrin engagement (11, 25, 30). We now show in the osteoclast
that PLC2 is critical for the integrin-mediated processes of
adhesion, migration, and bone resorption (Fig. 1 and 3).
PLC2 is also required for integrin-mediated phosphorylation
of the kinases Src and PYK2 (Fig. 4). Importantly, in the
absence of PLC2, the adhesion-induced interaction of Src
with 3 integrin and PYK2 is dramatically reduced (Fig. 5) and
Src is not properly localized to the actin ring (Fig. 6). Finally,
we show that both the catalytic activity and the adapter do-
mains of PLC2 are required for proper Src localization (Fig.
8). These results implicate PLC2 as an important transducer
of integrin signals in the osteoclast.
The mechanism by which Src is regulated in response to
integrin signals is not fully understood. Phosphorylation at
Tyr527 by C-terminal Src kinase induces an intramolecular
interaction with the SH2 domains of Src that inhibits Src ac-
tivity, while autophosphorylation at Tyr416 is required for ac-
tivation of the kinase (28). Protein-protein interactions with
the SH2 and SH3 domains of Src can also relieve the intramo-
lecular inhibitory state and serve to activate Src. For instance,
FIG. 5. Protein-protein interactions between components of the integrin adhesion complex are decreased in PLC2/ cells. (A, B) WT and
PLC2/ preOCs were starved for 6 h and stimulated by adhesion to vitronectin for various times. Lysates were collected, normalized, and
immunoprecipitated with a Src monoclonal antibody (A) or a PYK2 monoclonal antibody (B). Immunoprecipitates were Western blotted (WB)
for the indicated proteins. (C) Whole-total cell input lysates (TCL) were Western blotted for the indicated proteins. Equal amounts of proteins
were loaded in each lane. (D) WT adherent osteoclasts were treated with U73122 (5 M) for 3 h or left untreated. Lysates were immunopre-
cipitated with a Src monoclonal antibody and Western blotted for the indicated proteins. The input lysates (TCL) were Western blotted for the
same proteins. Equal amounts of proteins were loaded in each lane.
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when the SH3 domain of Src interacts with the tail of the 3
integrin, following integrin clustering, phosphorylation of Src
at Tyr416 is induced (1). A less appreciated aspect of Src
regulation is the localization of Src to sites where it is activated
or the localization of activated Src near substrates, such as its
recruitment to clustered integrins.
Based on our results, we propose that PLC2 modulates
v3 integrin signaling by affecting the formation and/or sta-
bility of the integrin adhesion complex as well as the subcellu-
lar localization of Src. In support of this model, adhesion-
induced interactions of Src with 3 integrin and PYK2 are
significantly reduced in PLC2/ osteoclasts (Fig. 5A). This
FIG. 6. Total Src and activated Src and PYK2 are mislocalized in PLC2/ osteoclasts. WT BMDM, retrovirally transduced with pMX empty vector
(A, D, G, J, and M), and PLC2/ BMDM, retrovirally transduced with pMX-NFAT2 (B, E, H, K, and N) or pMX-PLC2 (C, F, I, L, and O), were
grown in differentiation medium for 5 to 7 days to allow osteoclast differentiation. Cells were then fixed and stained with phalloidin (A to C) or incubated
with antibodies to PYK2 (D to F), p402 PYK2 (G to I), Src (J to L), or p416 Src (M to O). An asterisk marks each mature osteoclast present in a field.
All other cells are immature preOCs, macrophages, or stromal cells. Arrows mark the area at or near the actin sealing ring in mature osteoclasts. In panels
H and N, a dotted line delineates the edge of the mature osteoclast. Images were captured using an Olympus IX70 inverted microscope (60 APO,
1.4-numerical-aperture lens), with a CoolSnap camera, and analyzed using Metamorph software. Scale bar, 5 m.
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FIG. 7. Both catalytic activity and adapter function of PLC2 are required for bone resorption in osteoclasts. (A) PLC2/ BMDM were retrovirally
transduced with pMX-PLC2, PLC2-SH2 (construct carrying the mutations R564K/R672K), or the PLC H/F mutant (catalytically inactive construct with
mutated H327F/H372F). Cells were grown in the presence of 10 ng/ml M-CSF and 100 ng/ml RANKL for 5 to 8 days, fixed, and TRAP stained. TRAP
osteoclasts were observed using a light microscope with a 10objective. (B) Infected BMDM were lysed and Western blotted (WB) for PLC2 expression. Actin
expression served as a loading control. (C) Transduced proteins were immunoprecipitated using a FLAG antibody, and production of IP3 was determined using
a radioactive probe. Lipase activity is expressed as percentage of the WT PLC2 level, which was given an arbitrary value of 100. (D, E) BMDM infected with
pMX-PLC2 or coinfected with indicated PLC2 mutants plus NFAT2 were plated on dentin and grown in differentiation medium for 10 days. After cells were
removed, pits were visualized by staining with peroxidase-conjugated wheat germ agglutinin (E). Area of resorbed bone was determined using Image J software
(D). Scale bar, 20 m. (F) Plc2/ BMDM were retrovirally infected with Plc2 or PLC2 mutants SH2 and H/F plus NFAT2 and grown in differentiation
medium for 5 to 8 days. Osteoclasts were fixed and immunostained with PLC2 antibody.
3619
 o
n
 January 11, 2014 by guest
http://m
cb.asm
.org/
D
ow
nloaded from
 
indicates that PLC2, which itself has been shown to interact
with PYK2 (25) (Fig. 5B), can modulate either the formation
or the stability of the integrin adhesion complex. Second, the
aberrant localization of Src in the absence of PLC2 may result
from decreased recruitment of Src to the integrin complex or
instability of the complex. It is important to note that low levels
of Src are localized to the area of the actin ring in PLC2/
osteoclasts (Fig. 6K); however, in WT cells the majority of total
cellular Src is localized to this site of adhesion (Fig. 6J). De-
creased recruitment of Src to the cell periphery was not a result
of lower expression levels of total Src in PLC2-null cells
(Fig. 3A).
Genetic ablation of Src in the osteoclast results in a dramatic
phenotype characterized by a complete loss of the actin ring
(3). The presence of low levels of Src at the membrane in
PLC2/ cells may explain the presence of actin rings in these
cells when they are plated on glass (Fig. 6B). In contrast,
PLC2/ osteoclasts plated on bone (more physiologic) do
not exhibit normal actin rings but display disorganized actin
structures in the middle of the cell (Fig. 1H). Unlike osteo-
clasts plated on glass, osteoclasts on a bone surface polarize to
form a distinct three-dimensional structure; therefore, it is
possible that while PLC2 is not required for the formation of
the actin ring on glass, per se, it is essential for osteoclast
FIG. 8. Both catalytic activity and adaptor function of PLC2 are required for Src localization in osteoclasts. WT or PLC2/ BMDM,
retrovirally transduced with empty vector (pMX), NFAT2 alone, full-length PLC2, or PLC2 mutants SH2 and H/F plus NFAT2, were grown
on glass in the presence of 10 ng/ml M-CSF and 100 ng/ml RANKL for 5 to 8 days. Upon osteoclast formation, cells were fixed and stained for
actin (A, D, G, J, and M) or Src (B, E, H, K, and N). Images were obtained with an Olympus IX70 inverted fluorescence microscope using a 20
APO lens. Panels C, F, I, L, and O each represent a field of Src-stained images enlarged fourfold. Scale bar, 10 m.
3620 EPPLE ET AL. MOL. CELL. BIOL.
 o
n
 January 11, 2014 by guest
http://m
cb.asm
.org/
D
ow
nloaded from
 
polarization and formation of tight adhesions on the physio-
logical bone substrate. In support of this hypothesis, PLC2/
cells have adhesion and spreading defects as well as decreased
abilities to resorb bone, an indication of aberrant functionality.
PLC2 becomes phosphorylated in response to integrin en-
gagement (see Fig. S1 in the supplemental material) (25), and
this phosphorylation event is mediated by Src (10, 30). Here,
we provide evidence that PLC2 is important for regulating
the subcellular localization and integrin-mediated activation of
Src. How, then, could PLC2 be working both downstream and
upstream of Src? In some cases, such as the activation of Vav3,
Src is important; however, Vav3/ osteoclasts show decreased
Src phosphorylation following attachment (10). Here, one pos-
sibility is that following integrin engagement Src can promote
PLC2 phosphorylation and thus helps to activate its lipase
activity, whereas during the spreading process, PLC2, via its
SH2 and SH3 domains, may serve a scaffolding function inde-
pendent of its catalytic activity to recruit Src to the adhesion
complex. This is supported by the following findings: (i) inhi-
bition of PLC catalytic activity by U73122 fails to induce
Src/PYK2/3 association following integrin engagement (Fig.
5D) and (ii) the catalytic activity and the SH2 adapter motifs of
PLC2 are independently required for proper Src localization
at the actin rings of mature osteoclasts (Fig. 8). As a conse-
quence of these integrin dysfunctions, both PLC2 mutants, as
in PLC2/ cells, fail to support proper osteoclast function
(i.e., bone resorption).
Another possibility is that the catalytic activity of PLC2
may be required for PYK2 activation and consequently Src
localization. PYK2 autophosphorylation at Tyr402 is a calcium-
dependent event that occurs independent of Src activity (34),
and autophosphorylation of the PYK2 homologue focal adhe-
sion kinase has been shown to be critical for recruitment of Src
to focal adhesions in fibroblast cells (35). Here, we find that
PLC2-null cells have decreased levels of Tyr402 PYK2 in
response to integrin engagement (Fig. 4A and 6). This may
contribute to the abnormal Src localization in these cells. Fur-
thermore, treatment with the PLC inhibitor U73122, which
may influence tyr402 phosphorylation of PYK2, disrupted the
Src/PYK2/3 adhesive complex in adherent WT osteoclasts. In
further support of a role for the lipase activity of PLC2,
osteoclasts carrying the PLC2 catalytic domain mutant dis-
played improper Src localization (Fig. 8). Finally, it is also
possible that PLC2, via its SH2 motif, can bind to PYK2,
thereby recruiting both PYK2 and Src to the integrin complex.
Adhesion-dependent association between PLC SH2 motifs
and PYK2 in osteoclasts has been previously shown (25). Im-
portantly, our data for PLC2-deficient osteoclasts indicate
that total PYK2 is properly localized at the actin ring, while its
activated form, pPYK2 Y402, is barely detectable. This obser-
vation would suggest that PLC2 is required for both PYK2
phosphorylation and the recruitment/stability of the activated
protein at the sealing zone of the osteoclast, where it can
interact with Src and v3. This could explain the decreased
formation of the Src/PYK2/3 complex that we observe in
PLC2-null osteoclasts in response to integrin engagement
and, more importantly, the abnormal localization of Src in cells
carrying the PLC2 SH2 mutations.
ITAM-containing receptors Dap12 and FcR have been in-
volved in integrin signaling in several cell types, including the
osteoclasts. Interestingly, however, Src is normally phosphory-
lated in Dap12/FcR/ osteoclasts (reference 40 and data not
shown), suggesting that the mechanism by which PLC2 con-
trols Src activation downstream of the integrin receptor is
ITAM independent. Both PLC1 and PLC2 are suggested to
participate in integrin and ITAM signaling. Our studies from
PLC2-null mice clearly suggest a nonredundant role for these
two isoforms during both osteoclast differentiation and activity.
A differential and nonredundant role for PLC1 and -2 in NK
cells has been recently reported (29). Here, we show that
PLC2 is specifically important for the integrin-mediated pro-
cesses in the osteoclast since the phenotype persists in
PLC2/ cells despite the presence of normal PLC1 expres-
sion. Furthermore, only PLC2, and not PLC1, is phosphory-
lated upon integrin-mediated adhesion. We cannot, however,
rule out that PLC1 may still be playing a role in activating
integrin signaling in the osteoclast. For example, we have
found that PLC1, and to a lesser extent PLC2, is primarily
activated by M-CSF (20). It is possible that PLC1 could con-
tribute to integrin activation via an M-CSF-dependent mech-
anism. Since deletion of PLC1 in the mouse results in
embryonic lethality (13), further experiments are required.
In conclusion, our data suggest that PLC2 acts as a mod-
ulator of integrin signaling in the osteoclast by regulating the
activation and protein-protein interactions of adhesion com-
plex kinases, through localization and/or stabilization of Src at
integrin adhesion complexes.
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